Skip to content

A clinical trial to compare two drugs bupivacaine and ropivacaine in TAP block for pain relief after completion of surgery in patients undergoing caesarean section

Comparision of bupivacaine 0.25% and ropivacaine 0.5% in transeversus abdominis plane block for postoperative analgesia in lower segment caesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036392
Enrollment
50
Registered
2021-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Injection Bupivacaine HCL 0.25%, Injection Ropivacaine HCL 0.5%: Inj Bupivacaine 0.25% and Inj Ropivacaine 0.5% administered via Transeversus Abdominis Plane block 20 ml on each side (t

Sponsors

Dr Hetal N Kanabar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status 1 or 2, patients giving valid consent, undergoing elective lower segment caesarean section under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Known allergy to local anaesthetic agents, patients who are receiving any non-steroidal antiinflammatory drugs or opioids 48 hours prior to surgery, patients with any contraindication to spinal anaesthesia, thrombocytopenia, patients requiring general anaesthesia, local infection at the site of injection

Design outcomes

Primary

MeasureTime frame
First dose of rescue analgesic will be given when VAS Score more than or equal to 6Timepoint: Upto 36 hours after giving TAP block

Secondary

MeasureTime frame
Local site infection or haematoma, any secondary complications of local anaesthetic agents such as cardiotoxicity or neurotoxicityTimepoint: Upto 36 hours after giving TAP block

Countries

India

Contacts

Public ContactDr Hetal N Kanabar

GMERS Medical College, Junagadh

kanabarhetal@yahoo.com9909960401

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026